Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosis
Treatment of a 13.5-year-old boy with severe primary osteoporosis and multiple vertebral deformities with denosumab (Dmab) 60 mg subcutaneously every 3 months for 30 months, resulted in significant clinical, radiologic and densitometric improvement. During the second year of treatment, 2 episodes of...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2026-06-01
|
| coleção: | Bone Reports |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2352187226000082 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|